Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01319
|
|||||
| Drug Name |
Temocaprilate
|
|||||
| Synonyms |
(+)-(2S,6R)-6-(((1S)-1-carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; 2-(4-Carboxymethyl-5-oxo-2-thiophen-2-yl-[1,4]thiazepan-6-ylamino)-4-phenyl-butyric acid; 2D6A12Q12R; AC1L9E45; AJ-48035; AK116088; AKOS016010295; API0000849; AX8152551; BDBM50024710; O437; RNH 5139; RNH-5139; RS 5139; RS-5139; RT-015901; SCHEMBL498916; TL8000320; Temocapril Diacid; Temocaprilat; Temocaprilat [INN:BAN]; ZINC4099102; temocaprilate
|
|||||
| Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H24N2O5S2
|
|||||
| Canonical SMILES |
C1C(SCC(C(=O)N1CC(=O)O)NC(CCC2=CC=CC=C2)C(=O)O)C3=CC=CS3
|
|||||
| InChI |
InChI=1S/C21H24N2O5S2/c24-19(25)12-23-11-18(17-7-4-10-29-17)30-13-16(20(23)26)22-15(21(27)28)9-8-14-5-2-1-3-6-14/h1-7,10,15-16,18,22H,8-9,11-13H2,(H,24,25)(H,27,28)/t15-,16-,18-/m0/s1
|
|||||
| InChIKey |
KZVWEOXAPZXAFB-BQFCYCMXSA-N
|
|||||
| CAS Number |
CAS 110221-53-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 448.6 | Topological Polar Surface Area | 161 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
0.3
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:9436
|
|||||
| DT(s) Transporting This Drug | MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [2] | |
| MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [3] | ||
| PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [4] | ||
| References | ||||||
| 1 | National Center for Advancing Translational Science-Inxight: drug (2D6A12Q12R) | |||||
| 2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
| 3 | Pharmacogenetics of membrane transporters: an update on current approaches. Mol Biotechnol. 2010 Feb;44(2):152-67. | |||||
| 4 | Transporter-mediated Drug Interactions. Drug Metab Pharmacokinet. 2002;17(4):253-74. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.